We welcome our new colleague Sara del Palacio to the team!

Inhibitec Antibodies has been one of the startups selected in the ‘Programa Personal Tecnico I+D’ supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN) to expand its scientific team with the addition of an R&D technician (RH23-XX-025).
We greatly appreciate the support of SODERCAN for Inhibitec since the beginning of our project.

https://boc.cantabria.es/boces/verAnuncioAction.do?idAnuBlob=386579

Share the Post:

Inhibitec is recipient of the grant CPP2022-009666 to develop a public-private collaborative project

Towards a new therapy in psoriasis and psoriatic arthritis Inhibitec Anticuerpos S.L. has been selected as a recipient of the grant CPP2022-009666, supporting the development...

Spotlight pitch finalist (Basel Switzerland 20-22nd March, 2023)

Inhibitec is selected as finalist in the BIO-Europe Spring Startup Spotlight competition. This exciting competition offers entrepreneurs an affordable opportunity to engage with top-tier investors...

Attendance at the IMMUNOLOGY 2023 congress (11-15th May 2023)

World Lupus Day was celebrated on 10th May. At Inhibitec we were very proud to share our progress on the effects of BAMBI deficiency in...

We welcome our new colleague Sara del Palacio to the team!

Related Posts

Inhibitec is recipient of the grant CPP2022-009666 to develop a public-private collaborative project

Spotlight pitch finalist (Basel Switzerland 20-22nd March, 2023)

Attendance at the IMMUNOLOGY 2023 congress (11-15th May 2023)